Companies / Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc.
Nasdaq: VRDNCIK 1590750WALTHAM, MA
Financials · FY2017
Ownership
113.3M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.05% | 57,636 |
| 10%+ / strategic | 8.93% | 10,120,350 |
| Institutions | 89.92% | 101,875,279 |
| Public float | 1.09% | 1,239,004 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Mahoney Stephen F.CEOPresident and CEO · Director | 0.03% | 33,130 |
Beetham Thomas W.Chief Operating Officer | 0.01% | 13,271 |
Harmon SethChief Financial Officer | <0.01% | 7,790 |
Tousignant JenniferChief Legal Officer | <0.01% | 3,445 |
Tripuraneni RadhikaChief Medical Officer | — | — |
Institutional holders 238
View all →| Holder | Value | % of shares |
|---|---|---|
| $447.64M | 12.70% | |
| $174.65M | 4.95% | |
| $157.09M | 7.55% | |
| $135.64M | 3.85% | |
| $121.82M | 3.46% | |
| $120.83M | 3.43% | |
| $112.52M | 5.41% | |
| $78.57M | 2.23% | |
| $61.35M | 1.74% | |
| $55.46M | 1.57% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mahoney Stephen F. CEO | Other | Common Stock | $223.6K | -7K -18.18% | 33,349 0.03% of shares | low |
| Mar 3, 2026 | Mahoney Stephen F. CEO | Other | Common Stock | $223.6K | -8K -18.71% | 33,130 0.03% of shares | low |
| Mar 3, 2026 | Beetham Thomas W. Executive | Other | Common Stock | $92.0K | -3K -18.58% | 13,361 0.01% of shares | low |
| Mar 3, 2026 | Beetham Thomas W. Executive | Other | Common Stock | $92.0K | -3K -19.12% | 13,271 0.01% of shares | low |
| Dec 31, 2025 | Tousignant Jennifer Executive | Sell | Common Stock | $70.8K | -2K -100.00% | 0 0.00% of shares | low |
| Mar 3, 2026 | Harmon Seth Executive | Other | Common Stock | $61.3K | -2K -20.55% | 7,850 <0.01% of shares | low |
| Mar 3, 2026 | Harmon Seth Executive | Other | Common Stock | $61.3K | -2K -21.16% | 7,790 <0.01% of shares | low |
| Mar 3, 2026 | Tousignant Jennifer Executive | Other | Common Stock | $50.6K | -2K -32.40% | 3,494 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G/A | — |
| Kynam Capital Management, LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VRDN | — | 92790C104 |